2Stephcns RJ Johnson DH.Treatment and outcomes for elderly patients with small cell lung cancer.Drugs Aging, 2000,17(3):229
3Ricci,Antonuzzo A ,Gelli L,et al,Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer :amultieenter phase Ⅱ study.Lung Cancer,2000,27(2):75
4[1]Fry W, Phillips, Menck H. Ten-year survey of lung cancer treatment and survival in hospitals in United States. Cancer,1999, 86:1867
5[2]Socinski M. Chemotherapy for stage Ⅳ non-small cell lung cancer: An evidence-based guide for the practicing clinican. Philadelphia: WB Saunders Company, 2001, 307
6[3]Ng R, Boer RD, Park A, et al. Non small cell lung cancer(NSCLC): Are elderly patients being under-treated? ASCO Pro,2004, 7118
7[4]Hensing TA, Peterman AH, Schell MJ, et al. The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage ⅢB or Ⅳ nonsmall cell lung carcinoma triated with carboplatin and paclitaxel. Cancer, 2003, 98(4) :779
8[5]Lebitasy MP, Monnet L, Depierre A, et al. Management of elderly lung cancer patients in France: A national prospective survey by the French intergroup of thoracic oncology (WCT).ASCO Pro, 2004, 8163
9[6]Okamoto H, Kudoh H, Nagatomo A, et al. A combination chemotherapy of carboplatin and irinotecan in elderly patients with small cell lung cancer (SCLC). ASCO Pro, 2004, 7212
10[7]FukudaM, Oka M, SoejimaY, etal. Elderly (≥70)smallcell lung cancer (SCLC) chemotherapy: A phase Ⅰ study of carboplatin (CBDCA) and etoposide (VP-16). ASCO Pro,2004, 7217
